StockData
Polomar Health Services, Inc. logo

Polomar Health Services, Inc. (PMHS) stock

PMHSOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 3/30
$0.12−0.01 (-4.00%)

Close on Oct 19, 2026Market cap $3.37MP/E –Yield –

What Polomar Health Services keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

Gross margin61.1%vs 52.9%
Operating margin-295.0%vs -42.9%
EBITDA margin-2.71%vs -30.2%
Net margin-298.3%vs -39.9%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on equity-257.9%vs -53.5%
Return on assets-184.7%vs -40.7%
Return on invested capital-206.7%vs -33.0%

How hard the assets work

Revenue per dollar of assets0.62vs 0.39
Inventory turns a year14.22vs 2.68
Revenue per employee$528.74Kvs $405.05K
Profit per employee-$1.58Mvs -$704.12K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by $178.87K.

Cash and short-term investments$178.87K
EBITDA, trailing twelve months-$85.97K

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

4 of 9 tests passed

Beneish M-Score

Eight variables that flag accounts shaped to look better than they are.

-123.93
No flag

How the shares have traded

Total return includes reinvested dividends, to the close on Oct 19, 2026

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

PMHSS&P 500
PeriodPMHSS&P 500DifferencePMHS per yearS&P 500 per year
1 month-40.6%+0.6%−41.2 pts
3 months+1.7%+3.4%−1.7 pts
Year to date-85.0%+13.3%−98.3 pts
1 year-40.0%+16.6%−56.6 pts
3 years-90.8%+86.4%−177.1 pts-54.8%+23.1%
5 years-99.9%+81.9%−181.8 pts-76.1%+12.7%
10 years-97.0%+318.9%−415.9 pts-29.6%+15.4%

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M PMHS shares were sold short on Oct 30, 2026. At recent volumes it would take 1.0 days to buy them back.

Shares sold shortDays to cover

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20261,712–23,2361.0
Aug 31, 2026940-81.0%12,4051.0
Aug 14, 20264,946+1372.0%9,0341.0
Jul 31, 20263360.0%4,8841.0
Jul 15, 2026336-0.3%1033.3
Jun 30, 20263370.0%1212.8
Jun 15, 2026337–1,1541.0
Jan 30, 20265650.0%1343.5
Jan 15, 2026565-0.5%2282.5
Dec 31, 2025568-0.4%2562.2
Dec 15, 20251,140-0.2%11000.0
Nov 28, 20251,142–2742.3

Every measure, in full

36 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
–

Share statisticsIndustry

Shares Change (YoY)
1.06%
10.9%
Shares Change (QoQ)
0.81%
0.57%
Float
28M
49M
Shares Held by Insiders
0.50%
11.2%

MarginsIndustry

Gross Margin
61.1%
52.9%
Operating Margin
-295.0%
-42.9%
Profit Margin
-298.3%
-39.9%
EBITDA Margin
-2.71%
-30.2%

Returns on capitalIndustry

Return on Equity (ROE)
-257.9%
-53.5%
Return on Assets (ROA)
-184.7%
-40.7%
Return on Invested Capital (ROIC)
-206.7%
-33.0%

Financial positionIndustry

Interest Coverage
-90.30
-6.20

GrowthIndustry

Revenue Growth (YoY)
7688.8%
5.71%
Revenue Growth (3Y CAGR)
165.8%
2.25%

EfficiencyIndustry

Asset Turnover
0.62
0.39
Inventory Turnover
14.22
2.68
Revenue Per Employee
$528.74K
$405.05K
Profits Per Employee
-$1.58M
-$704.12K
Employee Count
6
75

Income statement (TTM)Industry

Revenue
$3.17M
$58.79M
Gross Profit
$1.94M
$103.58M
Operating Income
-$9.36M
-$21.49M
Net Income
-$9.46M
-$22.47M
EBITDA
-$85.97K
-$17.14M
EPS (Diluted)
-$0.34
-$0.83

Balance sheetIndustry

Net Cash (Debt)
$178.87K
$15.35M
Net Cash Per Share
$0.01
$0.71
Equity (Book Value)
-$1.06M
$49.84M
Book Value Per Share
-$0.04
$1.45
Tangible Book Value
-$1.06M
$23.91M

Cash flow (TTM)Industry

Operating Cash Flow
-$6.96K
-$12.17M

Taxes and interestIndustry

Interest Expense
$103.66K
$3.07M

Scores and fair valueIndustry

Piotroski F-Score
4
4
Beneish M-Score
-123.93
-2.62

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?